Form 4: BioLife Solutions CFO Sells Shares to Cover Tax Obligations Under Pre-Arranged Plan

BioLife Solutions' Chief Financial Officer, Troy Wichterman, sold 583 shares of common stock for $22.46 per share to satisfy tax withholding obligations, as part of a pre-existing Rule 10b5-1 trading plan.

Summary

• Troy Wichterman, the Chief Financial Officer of BioLife Solutions Inc. (BLFS), reported a sale of common stock.
• The transaction involved the disposition of 583 shares of common stock on May 28, 2025.
• Each share was sold at a price of $22.46.
• Following this transaction, Mr. Wichterman beneficially owns 187,727 shares of common stock directly.
• The sale was executed under a Rule 10b5-1(c) trading plan, which was adopted on February 24, 2022.
• The primary purpose of this sale was to satisfy tax withholding obligations related to the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The transaction is neutral in sentiment as it is a routine sale for tax withholding purposes under a pre-arranged trading plan, not indicative of a change in management's outlook on the company.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing details a routine insider transaction for tax purposes, which is a common occurrence in the biotechnology and life sciences industry, particularly for executives receiving equity compensation.

Stakeholder Impact

• Shareholders: The sale of a small number of shares for tax purposes by a CFO is generally not considered a significant event that would materially impact shareholder value or confidence, especially when executed under a 10b5-1 plan.

Key Dates

Keywords

BioLife Solutions, BLFS, SEC Form 4, Insider Trading, Stock Sale, Troy Wichterman, Chief Financial Officer, Tax Withholding, Rule 10b5-1 Plan, Restricted Stock